Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Zepbound (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
If blood sugar targets are not being met effectively on one medication, the dual action of tirzepatide might provide superior glucose management
Which option, Sermorelin or GLP-1 injections, is better suited for long-term weight management
and Priya Jaisinghani, M.D
Association of GLP-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases (JAMA Internal Medicine)
US$ 20.82
US$ 21.72
US$ 21.12
